Edap TMS SA (EDAP)
2.47
-0.02
(-0.80%)
USD |
NASDAQ |
Nov 22, 16:00
2.47
0.00 (0.00%)
After-Hours: 20:00
Edap TMS Revenue (Annual): 65.41M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.41M |
| December 31, 2022 | 58.12M |
| December 31, 2021 | 52.14M |
| December 31, 2020 | 47.58M |
| December 31, 2019 | 50.28M |
| December 31, 2018 | 46.27M |
| December 31, 2017 | 40.48M |
| December 31, 2016 | 39.41M |
| December 31, 2015 | 35.79M |
| December 31, 2014 | 35.62M |
| December 31, 2013 | 31.98M |
| December 31, 2012 | 33.51M |
| December 31, 2011 | 31.08M |
| December 31, 2010 | 31.43M |
| Date | Value |
|---|---|
| December 31, 2009 | 34.70M |
| December 31, 2008 | 33.84M |
| December 31, 2007 | 30.61M |
| December 31, 2006 | 25.47M |
| December 31, 2005 | 25.88M |
| December 31, 2004 | 27.54M |
| December 31, 2003 | 20.88M |
| December 31, 2002 | 18.90M |
| December 31, 2001 | 21.50M |
| December 31, 2000 | 25.25M |
| December 31, 1999 | 20.41M |
| December 31, 1998 | 25.99M |
| December 31, 1997 | 37.04M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
47.58M
Minimum
2020
65.41M
Maximum
2023
54.71M
Average
52.14M
Median
2021
Revenue (Annual) Benchmarks
| DBV Technologies SA | -- |
| Cellectis SA | 0.755M |
| Genfit SA | 30.92M |
| Adaptimmune Therapeutics PLC | 60.28M |
| Akari Therapeutics PLC | -- |